RadNet traded at $72.61 this Tuesday September 8th, decreasing $1.11 or 1.50 percent since the previous trading session. Looking back, over the last four weeks, RadNet lost 8.27 percent. Over the last 12 months, its price rose by 1.67 percent. Looking ahead, we forecast RadNet to be priced at 72.04 by the end of this quarter and at 67.54 in one year, according to Trading Economics global macro models projections and analysts expectations.
RadNet, Inc., is a company, which is engaged in providing freestanding, fixed-site outpatient diagnostic imaging services in the United States. The Company operates through joint ventures with hospitals, approximately 331 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Its centers provide physicians to facilitate the diagnosis and treatment of diseases and disorders. The Company’s services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. In addition, it has a software division to facilitate imaging business. The Company through its subsidiary, eRAD, Inc. sales computerized systems that distribute, display, store and retrieve digital images.